Federated Hermes’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,202
Closed -$90K 2378
2021
Q4
$90K Sell
4,202
-241,148
-98% -$4.75M ﹤0.01% 1718
2021
Q3
$4.53M Buy
245,350
+128,790
+110% +$2.59M 0.01% 846
2021
Q2
$2.5M Buy
116,560
+56,560
+94% +$1.15M ﹤0.01% 1021
2021
Q1
$1.16M Buy
+60,000
New +$1.06M ﹤0.01% 1313

Other funds holding OCDX

Federated Hermes's OCDX Position: Q1 2022 in Review

Federated Hermes sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 4,202 shares — an estimated $90K sold.

Federated Hermes first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $4.53M in Q3 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Federated Hermes reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Federated Hermes sold 4,202 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $90K.
  • Federated Hermes first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Federated Hermes's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.53M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.